{Reference Type}: Journal Article
{Title}: A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma.
{Author}: Park JW;Pereira TT;Rotta I;Mendonça Lima T;Aguiar PM;Visacri MB;
{Journal}: Int J Clin Pharm
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 7
暂无{DOI}: 10.1007/s11096-024-01787-x
{Abstract}: <B>BACKGROUND: </B>Treating multiple myeloma is complex, and providing supportive care through an interdisciplinary approach is essential.<BR><B>OBJECTIVE: </B>To report and synthesize pharmacists' clinical activities and impact on the care of patients with multiple myeloma.<BR><B>METHODS: </B>This was a scoping review that followed the PRISMA-ScR reporting recommendations. A search was conducted in PubMed, Embase, Web of Science, Scopus, and LILACS from the inception of the database until January 10th, 2024. Papers that reported pharmacists' clinical activities in the care of patients with multiple myeloma were included. Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2 was used to characterize the pharmacists' clinical activities. The results are presented as a narrative and tabular synthesis.<BR><B>RESULTS: </B>A total of 2885 records were identified, 10 of which met the inclusion criteria. Pharmacists' clinical activities related to 'direct patient care' (n = 8) and 'medication counseling, education, and training' (n = 7) were the most cited. Most were provided for patients (n = 8), by one-on-one contact (n = 9), and through face-to-face communication method (n = 8), with patient counseling being the main action taken by pharmacists (n = 7). Materials that supported pharmacists' actions were cited in five studies. Integrating pharmacists into interdisciplinary teams led to improved process, clinical, humanistic, and economic outcomes.<BR><B>CONCLUSIONS: </B>This scoping review emphasizes pharmacists' clinical activities in improving the care of patients with multiple myeloma. There is a need to develop studies with patient-reported outcomes and comprehensive reporting of pharmacists' clinical activities to ensure reproducibility and effective implementation in clinical practice.